References
- GOLD. 2019. [cited 2019 Nov 14]. Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-POCKET-GUIDE-FINAL_WMS.pdf
- GINA. 2019. [cited 2020 May 31]. Available from: https://ginasthma.org/wp-content/uploads/2020/04/Main-pocket-guide_2020_04_03-final-wms.pdf
- WHO. 2018 [cited 2020 Aug 24]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death
- WHO. 2017 [cited 2020 Aug 24]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/asthma
- Dijkstra A, Postma DS, Noordhoek JA, et al. Expression of ADAMs (“a disintegrin and metalloprotease”) in the human lung. Virchows Arch. 2009;454:441–449.
- Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Gene Dev. 2003;17:7–30.
- Zou J, Zhu F, Liu J, et al. Catalytic activity of human ADAM33. J Biol Chem. 2004;279:9818–9830.
- Cakebread JA, Haitchi HM, Holloway JW, et al. The role of ADAM33 in the pathogenesis of asthma. Semin Immunopathol. 2004;25:361–375.
- Sadeghnejad A, Ohar JA, Zheng SL, et al. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res. 2009;10:21.
- Moon C, Preston GM, Griffin CA, et al. The human aquaporin-CHIP gene. Structure, organization, and chromosomal localization. J Biol Chem. 1993;268:15772–15778.
- Ishibashi K, Hara S, Kondo S. Aquaporin water channels in mammals. J Clin Exp Nephrol. 2009;13:107–117. .
- Verkman AS. Role of aquaporins in lung liquid physiology. Respir Physiol Neurobiol. 2007;159:324–330.
- Saadoun S, Papadopoulos MC, Hara-Chikuma M, et al. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature. 2005;434:786–792.
- Wang K, Feng YL, Wen FQ, et al. Decreased expression of human aquaporin‐5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease1. Acta Pharmacol Sin. 2007;28:1166–1174.
- Aggarwal NR, Chau E, Garibaldi BT, et al. Aquaporin 5 regulates cigarette smoke induced emphysema by modulating barrier and immune properties of the epithelium. Tissue Barriers. 2013;1:e25248.
- Song Y, Verkman AS. Aquaporin-5 dependent fluid secretion in airway submucosal glands. J Biol Chem. 2001;276:41288–41292.
- Zhang J, Gong L, Hasan B, et al. Use of aquaporins 1 and 5 levels as a diagnostic marker in mild-to-moderate adult-onset asthma. Int J Clin Exp Pathol. 2015;8:14206.
- Ning Y, Ying B, Han S, et al. Polymorphisms of aquaporin5 gene in chronic obstructive pulmonary disease in a Chinese population. Swiss Med Wkly. 2008;138:573–578.
- Hansel NN, Sidhaye V, Rafaels NM, et al. Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease. PloS One. 2010;5:e14226.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
- Gautam S, Agrawal CG, Bid HK, et al. Preliminary studies on CD36 gene in type 2 diabetic patients from North India. Indian J Med Res. 2011;134:107–112.
- Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis. bio-x. cn). Cell Res. 2009;19:519–523.
- Holgate ST, Davies DE, Powell RM, et al. ADAM33: a newly identified protease involved in airway remodelling. Pulm Pharmacol Ther. 2006;19:03–11.
- Thongngarm T, Jameekornrak A, Limwongse C, et al. Association between ADAM33 polymorphisms and asthma in a Thai population. Asian Pac J Allergy Immunol. 2008;26:205.
- Korytina GF, Tselousova OS, Akhmadishina LZ, et al. Association of MMP3, MMP9, ADAM33, and TIMP3 polymorphisms with chronic obstructive pulmonary disease and its progression. Mol Biol. 2012;46:438–449.
- Tripathi P, Awasthi S, Gao P. ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma. Mediators Inflammation. 2014;2014:1–8.
- Raby BA, Silverman EK, Kwiatkowski DJ, et al. ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol. 2004;113:1071–1078.
- Kedda MA, Duffy DL, Bradley B, et al. ADAM33 haplotypes are associated with asthma in a large Australian population. Eur J Hum Genet. 2006;14:1027–1036.
- Schedel M, Depner M, Schoen C, et al. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir Res. 2006;7:91.
- Vergara CI, Acevedo N, Jiménez S, et al. A six-SNP haplotype of ADAM33 is associated with asthma in a population of Cartagena, Colombia. Int Arch Allergy Immunol. 2010;152:32–40.
- Wang X, Li L, Xiao J, et al. Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population. BMC Med Genet. 2009;10:132.
- El-Zaher AH, Nagy H, Farouk G, et al. Effect of a disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms and smoking in COPD. Egypt J Chest Dis Tuberc. 2012;61:275–280.
- Tan J, Liu AP, Sun C, et al. Association of ADAM33 gene polymorphisms with COPD in the Mongolian population of China. Ann Hum Biol. 2014;41:9–14.
- Laxmi KV, Subhakar K, Lakshmi BV, et al. Association of ADAM33 gene S1 and S2 transmembrane domain polymorphisms in COPD from South-Indian population. Egypt J Med Hum Genet. 2016;17:317–323.
- Zhou DC, Zhou CF, Toloo S, et al. Association of a disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms with the risk of COPD: an updated meta-analysis of 2,644 cases and 4,804 controls. Mol Biol Rep. 2015;42:409–422.
- Pabst S, Touron CP, Gillissen A, et al. ADAM33 gene polymorphisms in chronic obstructive pulmonary disease. Eur J Med Res. 2009;14:182–186.
- Blakey J, Halapi E, Bjornsdottir US, et al. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax. 2005;60:274–276.
- Liang S, Wei X, Gong C, et al. A disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms and the risk of asthma: a meta-analysis. Hum Immunol. 2013;74:648–657.
- Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 1995;57:439–454.
- Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 2002;418:426–430.